Stock chart
Analyses on Erika Carmel (4)
- March 31, 2026March 31, 2026
- Follow-up
Arika Carmel: Enforcement, litigation, and the trust discount on the equity
The NIS 1.5 million sanction is already behind the income statement, but the trust damage is not: the CE episode spread into an open enforcement process, an external examiner, a second administrative review, and a wider litigation web that continues to weigh on the equity story.
- Follow-up
Arika Carmel: The Aigen loan, offsets, and the related-party web in the balance sheet
Aigen’s debt to Arika does not function as a clean liquidity cushion because it sits inside an internal web of supplier offsets, deferred compensation to the controlling shareholder, and interest-bearing deferrals that almost erase the gross asset.
- Follow-up
Arika Carmel: The placement, reverse split, and dilution path that will shape 2026
The March 2026 financing is a small but critical bridge round: it was not yet closed at the financial-statement signing date, it depends on a reverse split and bylaw changes, and it already maps not only the immediate dilution but also the economics of the next private round if…
Arika Carmel 2025: The operating improvement is real, but the cash cushion barely moved
Arika Carmel delivered real operating improvement in 2025, but the liquidity cushion barely expanded and the business model is still shifting underneath the reported numbers.
